RECOMBINATE 500 IU

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Saatavilla:

TEVA MEDICAL MARKETING LTD.

ATC-koodi:

B02BD05

Lääkemuoto:

POWDER FOR SOLUTION FOR INJECTION

Antoreitti:

I.V

Valmistaja:

BAXTER S.A., BELGIUM

Terapeuttinen ryhmä:

COAGULATION FACTOR VII

Käyttöaiheet:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Valtuutus päivämäärä:

2010-07-01